INFLUENZA, HUMAN

This study tests new mRNA-based flu vaccines in 776 healthy adults aged 18 and older. The goal is to see how well the vaccines trigger an immune response and whether they are safe. Participants will be monitored for side effects like pain, fever, and fatigue. The results will hel…

This study compares two types of flu vaccines: a nasal spray and a shot. It involves 60 healthy adults aged 18-49. Researchers will measure immune responses in the nose and blood to see which vaccine triggers stronger protection. The goal is to improve future flu vaccines.

This study tests new mRNA-based seasonal flu vaccines in about 971 healthy adults aged 18 and older. The goal is to see how safe the vaccines are and how well they boost the immune system against flu. Researchers will measure antibody levels and track any side effects like pain, …

This study tests whether a specially formulated flu vaccine (Fluad) can prevent flu better than standard flu shots in adults aged 65 and older. About 35,800 participants will receive either the enhanced or standard vaccine and be monitored for flu cases. The goal is to see if the…

This study tests whether sending a letter (a 'nudge') from a pharmacist can encourage more adults to get their flu or travel vaccines. About 20,000 people in Alberta, Canada, are taking part. The researchers also want to see if getting vaccinated leads to fewer strokes in the fol…